Synergistic combinations of VR-1 antagonists and COX-2 inhibitors

Details for Australian Patent Application No. 2008277627 (hide)

Owner Novartis AG

Inventors Fox, Alyson; Lilley, Elliot; Nash, Mark; Sohal, Bindi

Agent Davies Collison Cave

Pub. Number AU-B-2008277627

PCT Pub. Number WO2009/010529

Priority 07112679.1 18.07.07 EP

Filing date 16 July 2008

Wipo publication date 22 January 2009

Acceptance publication date 27 October 2011

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/010529 Priority application(s): WO2009/010529

27 October 2011 Application Accepted

  Published as AU-B-2008277627

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008277628-Bicyclic heteroaryl compounds and their use as kinase inhibitors

2008277621-Device for dispensing a liquid